University Kidney Research Organization is located in Los Angeles, CA. The organization was established in 2002. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. University Kidney Research Organization is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, University Kidney Research Organization generated $377.6k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 2.8% each year. All expenses for the organization totaled $534.6k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
UNIVERSITY KIDNEY RESEARCH ORGANIZATION IS COMMITTED TO FUNDING THE DEVELOPMENT OF A REVOLUTIONARY SYNTHETIC KIDNEY, DERIVED FROM STEM CELLS, THAT WILL IMPROVE TREATMENT OF KIDNEY DISEASE AND REPLACE DIALYSIS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THROUGH ITS WEBSITE, ONLINE SOCIAL MEDIA PRESENCE, AND E-NEWSLETTERS, THE ORGANIZATION RAISES AWARENESS OF KIDNEY DISEASE AND RESEARCH BREAKTHROUGHS, PARTICULARLY SPOTLIGHTING THE WORK OF SCIENTISTS AT THE USC/UKRO KIDNEY RESEARCH CENTER AND THE KECK SCHOOL OF MEDICINE OF USC.
IN JANUARY 2023, UKRO MADE A DONOR-DIRECTED GIFT OF $100,000 TO THE KECK SCHOOL OF MEDICINE OF USC TO FUND THREE NOVEL KIDNEY RESEARCH PROJECTS AND TO FURTHER RESEARCH ACTIVITIES AT THE USC/UKRO KIDNEY RESEARCH CENTER.IN NOVEMBER 2023, UKRO MADE A DONOR-DIRECTED GIFT OF $141,068 TO THE KECK SCHOOL OF MEDICINE OF USC TO SUPPORT THE SYNTHETIC KIDNEY PROJECT AND THE USC PKD (POLYCYSTIC KIDNEY DISEASE) CENTER OF EXCELLENCE, INCLUDING THE USC KECK PKD CLINIC AND PRE-CLINICAL AND CLINICAL PKD RESEARCH INITIATIVES.IN NOVEMBER 2023, UKRO HELD AN EDUCATIONAL SALON FOR AFRICAN AMERICAN HEALTH CARE PROFESSIONALS TO LEARN ABOUT THE SYNTHETIC KIDNEY PROJECT AND TO DISCUSS ITS POTENTIAL IMPACT IN THEIR COMMUNITY.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Michelle Fairchild Secretary | Officer | 32 | $64,669 |
Lewis Kleinberg Director | Trustee | 3 | $14,500 |
Ammiel Najar Director | Trustee | 3 | $14,500 |
Kenneth Kleinberg President & Dir | OfficerTrustee | 6 | $0 |
Camila Koenig Director | Trustee | 1 | $0 |
Adela Koenig Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $359,759 |
Noncash contributions included in lines 1a–1f | $106,871 |
Total Revenue from Contributions, Gifts, Grants & Similar | $359,759 |
Total Program Service Revenue | $0 |
Investment income | $17,876 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $377,635 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $241,068 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $64,669 |
Compensation of current officers, directors, key employees. | $49,659 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $5,073 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $0 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $36,084 |
Office expenses | $2,456 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $1,957 |
All other expenses | $3,017 |
Total functional expenses | $534,645 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $24,178 |
Savings and temporary cash investments | $377,174 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $15,511 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $416,863 |
Accounts payable and accrued expenses | $980 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $980 |
Net assets without donor restrictions | $415,883 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $416,863 |
Over the last fiscal year, University Kidney Research Organization has awarded $300,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
UNIV OF SOUTHERN CAL PURPOSE: SCIENTIFIC STUDY | $100,000 |
UNIV OF SOUTHERN CAL PURPOSE: KIDNEY DISEASE RESEARCH | $200,000 |